Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Sort descending Organization
May
4
2022
Final Medicare Advantage and Part D Rule will Likely Require Medicare Advantage Plans to Update 2023 Bids under Maximum Out-of-Pocket (MOOP) Policy Changes Mintz
Oct
5
2018
Final Opioid Legislation Expands Treatment Options for Medicaid Beneficiaries with Substance Use Disorder Mintz
Jun
30
2022
Final Revision to HBCD Risk Determination Finds HBCD, as a Whole Chemical Substance, Presents an Unreasonable Risk Bergeson & Campbell, P.C.
Jun
25
2020
Final Risk Evaluation for Methylene Chloride Is First Completed under Lautenberg Act Amendments Bergeson & Campbell, P.C.
Feb
7
2017
Final Rule Modernizes Substance Use Disorder Patient Record Confidentiality Regulations McDermott Will & Emery
Mar
4
2019
Final Rule Regarding the Labeling of Bioengineered Foods Polsinelli PC
Jan
12
2017
Final Rules Released Covering 340B Ceiling Prices and Manufacturer Penalties McDermott Will & Emery
Jan
23
2017
Final Version of the Updated Coordinated Framework for the Regulation of Biotechnology Available Keller and Heckman LLP
Feb
11
2019
Finalized Guidance for Industry and FDA Staff on Public Warning and Notification of Firm-Initiated or FDA-Requested Recalls Keller and Heckman LLP
Feb
9
2024
Finalizing PFAS Detection Methods, EPA Moves Closer to Locating and Limiting Further PFAS Releases and Requiring Their Cleanup Hunton Andrews Kurth
Mar
8
2017
Finally! FDA Issues Draft Guidance on Interchangeable Biosimilars Katten
Mar
12
2014
Financial Industry Regulatory Authority (FINRA) Issues Investor Alert Concerning Bitcoin Trading and Speculation Proskauer Rose LLP
Jun
29
2013
Financial Innovation for Clean Energy Deployment: Congress Considers Expanding Master Limited Partnerships for Clean Energy Mintz
Feb
18
2019
Financial Services and the Marijuana Industry: the U.S. House Mulls Regulatory Reform for Financial Institutions and Cannabis-Related Businesses Ballard Spahr LLP
Aug
10
2017
Financing California’s Cannabis Businesses: Public Banking Model as a State-Level Solution Wilson Elser Moskowitz Edelman & Dicker LLP
Aug
30
2019
FinCEN Advisory Highlights Money Laundering Risks Related to Fentanyl Trafficking Ballard Spahr LLP
Jul
1
2020
FinCEN Issues Guidance to Financial Institutions on Hemp-Related Due Diligence Greenberg Traurig, LLP
Jan
25
2013
Fine Particle Emissions Rules Remanded- Stricter Clean Air Regulations for Nonattainment Areas Will Follow Barnes & Thornburg LLP
Mar
19
2018
First Amendment constraints on FDA’s regulation of health claims Keller and Heckman LLP
Aug
17
2015
First Amendment Protects Truthful Off-Label Speech by Drug Manufacturers Mintz
Jun
17
2018
First Amendment Still Trumps Prop 65 Mintz
Mar
23
2021
First Cannabis-Related Business SARS Penalty Against a Depository Institution K&L Gates
Nov
20
2019
First Circuit Class Action Litigation | Fall 2019 Greenberg Traurig, LLP
Mar
6
2020
First DOJ Enforcement under New Opioids Kickback Law Announced Dinsmore & Shohl LLP
Jul
10
2015
First Federal Appellate Court Holds a NonCash Reverse Payment Subject to Antitrust Scrutiny: Is the Third Circuit's Decision in King Drug a Turning Point? Proskauer Rose LLP
Mar
14
2022
First Genome-Edited Beef Cattle Cleared for Marketing by FDA ArentFox Schiff LLP
Oct
18
2016
First Handheld Device for Full Traumatic Brain Injury Assessment Stark & Stark
Nov
26
2019
First Indicators of FDA’s Policy Decision on CBD and Cannabis-Derived Ingredients: “Only Limited Data” and “Real Risks” Mintz
May
14
2015
First Look At False Marking Under The AIA - America Invents Act Foley & Lardner LLP
Oct
14
2014
First Mailbox Appeal to be decided by the Federal Court of Appeals in Brazil Michael Best & Friedrich LLP
Jan
18
2023
First Major Overhaul of Cosmetics Regulation Since FDR Administration Nelson Mullins
Aug
20
2012
First Mid Lake Weather Report from GVSU Varnum LLP
Feb
10
2016
First Monoclonal Antibody Biosimilar in U.S. Gets One Step Closer to FDA Approval Mintz
Jul
25
2023
First Nonprescription Birth Control Pill Approved for Marketing by FDA: A Milestone for Reproductive Health Mintz
Jul
12
2023
First Of Its Kind With More To Follow: NJDEP Settlement Proposal Addresses PFAS Contamination Giordano, Halleran & Ciesla, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins